Antibody response to SARS-CoV-2 in patients receiving glucocorticoids with or without tocilizumab for COVID-19-associated hyperinflammation

Marlou T. H. F. Janssen, Sofia Ramiro, Robert B. M. Landewé, C. sar Magro-Checa, R. my L. M. Mostard

Research output: Contribution to journalComment/Letter to the editorAcademic

3 Citations (Scopus)
Original languageEnglish
Pages (from-to)1362-1363
Number of pages2
JournalAnnals of the rheumatic diseases
Volume80
Issue number10
Early online date2021
DOIs
Publication statusPublished - 1 Oct 2021

Keywords

  • Covid-19
  • glucocorticoids
  • inflammation

Cite this